The two new sterically demanding secondary phosphines (C 6 H 4 -2-OMe)RPH ( 1a ) and (C 6 H 3 -2-OMe-3-Me)RPH ( 1b ) [R = CH(SiMe 3 ) 2 ] are synthesized by the reaction of RPCl 2 with 1 equiv of LiC 6 H 4 -2-OMe or LiC 6 H 3 -2-OMe-3-Me, respectively, followed by in situ reduction with LiAlH 4 . Metalation of 1 with Bu n Li, followed by metathesis with KOBu t, yields the potassium salts K{PR(C 6 H 4 -2-OMe)} ( 2a ) and K{PR(C 6 H 3 -2-OMe-3-Me)} ( 2b ). The reaction of K{PR(C 6 H 3 -2-OMe-3-Me)} with YbI 2 yields the diphosphide complex [Yb II {PR(C 6 H 3 -2-OMe-3-Me)} 2 (THF) 2 ] ( 3 ), in which the phosphides act as P, O -chelating ligands. In contrast, reaction of K{PR(C 6 H 4 -2-OMe)} with YbI 2 under similar conditions yields the unexpected alkoxophosphide complex [Yb II {PR(C 6 H 4 -2-O)}(THF)] 4 ·4Et 2 O ( 4 ), via an unusual ligand cleavage reaction involving the transfer of a methyl group from oxygen to phosphorus. Compounds 1 − 4 have been characterized by elemental analyses and multinuclear NMR spectroscopy and compounds 3 and 4 by X-ray crystallography. Compound 3 is monomeric in the solid state, with a distorted all- trans -octahedral geometry about the Yb center; compound 4 crystallizes as an unprecedented tetrameric cluster containing a Yb 4 O 4 cuboidal core. Multi-element NMR spectroscopy suggests that 4 maintains an oligomeric structure in THF solution. The P-containing side product formed in the synthesis of 4 has been isolated and identified as (Me)PR(C 6 H 4 -2-OMe) by comparison of its NMR and mass spectra with those of an authentic sample.
No takes yet. Share an insight, caveat, or question.
Clegg et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: